lunes, 27 de mayo de 2013

MARTES 28 DE MAYO DE 2013

Este martes 28 de Mayo de 2013 hay clase normal:


Flint : The role of the gut microbiota
in nutrition and health 

por:

Jesica Ramírez Villalobos

HVISTENDAHL: My Microbiome
and Me 

por: Jesica Ramírez Villalobos

Aprovecho para anexar las fotos del experimento que tienen que documentar:




Saludos


jueves, 4 de abril de 2013

My Microbiome and Me

Jesica Ramírez Villalobos, 4 de Junio, 2013

Diet promotes dysbiosis and colitis in susceptible hosts

Georgina López Cortés, 28 de Mayo, 2013

The role of the gut microbiota in nutrition and health

Jesica Ramírez Villalobos, 21 de Mayo, 2013

The gut microbiota—a clinical perspective on lessons learned

Paloma Perez Guerrero,  14 de Mayo, 2013


A framework for human microbiome research

Fernanda Navarro Maldonado, 7 de Mayo 2013

Cell-Free Culture Supernatant of Bifidobacterium breve CNCM I-4035 Decreases Pro-Inflammatory Cytokines in Human Dendritic Cells Challenged with Salmonella typhi through TLR Activation

Claudia Martínez Ruíz, 30 de Abril 2013

Fifty Shades of Immune Defense

Sandra Cervantes Ortíz 23 de Abril 2013


The gut microbiota — masters of host development and physiology

Georgina López Cortés 16 de Abril 2013

martes, 11 de enero de 2011

INfLAmmAtION Directions from the matrix

Emerging evidence reveals that components of the extracellular matrix can directly regulate inflammatory processes. Now, researchers have identified a role for the matrix component biglycan in the pathogenesis of lupus nephritis through its ability to induce expression of the B cell chemoattractant CXC-chemokine ligand 13 (CXCL13).

References

NaTuRE REvIEWS | Immunology vOLuME 11 | jaNuaRy 2011

ORIGINAL RESEARCH PAPER Moreth, K. et al.
The proteoglycan biglycan regulates expression
of the B cell chemoattractant CXCL13 and
aggravates murine lupus nephritis. J. Clin. Invest.
120, 4251–4272 (2010)